Gary Charles Robb, Chief Business Officer at CORCEPT THERAPEUTICS INC (CORT), sold 50,000 shares at $26.06 ($1.3M) on 2022-09-07, disclosed to the SEC on 2022-09-08.
Open-market sale of $1.3M CORT by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |